Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 2,834

Document Document Title
WO/2018/119716A1
Provided are a thioxanthone derivative photoinitiator, a radiation curable composition comprising the same and the use thereof. In particular, provided is thioxanthone derivative photoinitiator suitable to be in one drop filling process ...  
WO/2018/116107A1
Provided are IDO inhibitor compounds of Formula (I) and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of diseases ...  
WO/2018/099432A1
The present invention relates to a fused ring compound and a preparation method and application thereof. The fused ring compound is represented by general formula (I). The fused ring compound emits fluorescence at a short wavelength, and...  
WO/2018/100834A1
Provided is a composition that has excellent near-infrared ray absorption stability and is useful for an optical film. The composition includes at least two of the compounds represented by general formula 2 or general formula 5.  
WO/2018/091430A1
Compounds of the formula (I), wherein R1, R2, R3, R4 and R5 are as defined in claim 1. Furthermore, the present invention relates to agrochemical compositions which comprise compounds of formula (I), to preparation of these compositions,...  
WO/2018/089402A1
There are described RORγ Gamma modulators of the formula (I), (I) or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates, or prodrugs thereof, wherein all substituents are defined herein. Also provided are pharmaceutic...  
WO/2018/087064A1
The invention relates to a method for producing triarylorganoborates from organoboronic acid esters in the presence of an n-valent cation 1/n Kn+, comprising the anhydrous treatment of the reaction mixture, and to the use of the obtained...  
WO/2018/053240A1
Disclosed herein are compounds useful for modulating the mu-opioid receptor ("MOR") and/or delta-opioid receptor ("DOR"), and methods of using these compounds to treat diseases and conditions, such as pain. In particular, disclosed herei...  
WO/2018/020974A1
Provided are the following: a sulfonium salt which does not contain a toxic metal and which exhibits higher cationic polymerization performance and crosslinking performance than a tetrakis(pentafluorophenyl)borate salt; a heat- or photo-...  
WO/2018/014405A1
Provided are a light-emitting material, a preparation method therefor and an organic light-emitting diode using the light-emitting material. The light-emitting material has a single structure, a certain molecular weight, good solubility ...  
WO/2018/014407A1
A light-emitting material, a preparation method therefor, and an organic light-emitting diode made of the light-emitting material. The light-emitting material has a single structure, a determined molecular weight, good solubility and fil...  
WO/2018/014404A1
A light-emitting material, a preparation method therefor and an organic light-emitting diode using said light-emitting material. The light-emitting material is obtained by using m-bromothiophenol and 2-fluoro-4-bromobenzonitrile as start...  
WO/2018/013930A1
Embodiments of the present disclosure pertain to methods of opening a lipid bilayer by associating the lipid bilayer with a molecule that includes a moving component capable of moving (e.g., rotating) in response to an external stimulus;...  
WO/2018/003470A1
Because a sulfonium salt that does not contain a toxic metal and that exhibits polymerization performance and crosslinking reaction performance equal to or greater than those of a tetrakis (pentafluorophenyl) borate salt, a photoacid gen...  
WO/2017/220425A1
A specific mixture of polymerizable photoinitiators containing a thioxanthone group is disclosed. A method for manufacturing this mixture by flow chemistry is also disclosed.  
WO/2017/220205A1
The present invention relates to a compound, which can be used as an anti-bacterial and/or an anti-fungal agent as well as a zinc sensor. Moreover, the present invention relates to a pharmaceutical composition comprising said compound an...  
WO/2017/152725A1
Disclosed are a retinoid compound, a preparation method therefor, intermediates thereof and an application thereof. The retinoid compound I of the present invention has a good tumor growth inhibition rate.  
WO/2017/131047A1
The presentt invention addresses the problem of providing a photocuring method that obtains a crosslinked product (resin) quickly and efficiently, a compound used in the photocuring method, and a photocurable resin composition containing...  
WO/2017/129483A1
The invention relates to a novel hetero-diels-alder cross-linker, to methods for the production thereof and use thereof for reversibly crosslinked polymer systems.  
WO/2017/097746A1
The invention relates to a dextrorotatory enantiomer of a configurational stereoisomer of difethialone, referred to as a hetero-stereoisomer, of formula 3-(4'-bromobiphenyl-4-yl)-1-(4-hydroxythiocoumarin-3-yl)-1,2 ,3,4-tetrahydronaphthal...  
WO/2017/097744A1
The invention relates to a dextrorotatory enantiomer of the configurational stereoisomer of difethialone, referred to as a homo-stereoisomer, of formula 3-(4'-bromobiphenyl-4-yl)-1-(4-hydroxythiocoumarin-3-yl)-1,2 ,3,4-tetrahydronaphthal...  
WO/2017/097747A1
The invention relates to a levorotatory enantiomer of the configurational stereoisomer of difethialone, referred to as a hetero-stereoisomer, of formula 3-(4'-bromobiphenyl-4-yl)-1-(4-hydroxythiocoumarin-3-yl)-1,2 ,3,4-tetrahydronaphthal...  
WO/2017/097745A1
The invention relates to a levorotatory enantiomer of the configurational stereoisomer of difethialone, referred to as a homo-stereoisomer, of formula 3-(4'-bromobiphenyl-4-yl)-1-(4-hydroxythiocoumarin-3-yl)-1,2 ,3,4-tetrahydronaphthalen...  
WO/2017/075927A1
Disclosed in the present invention is a living free radical polymerization based on combined use of aromatic cyclic thia-(oxa-) thioketone, derivatives of the aromatic cyclic thia-(oxa-) thioketone and free radical initiators. According ...  
WO/2017/072792A1
The present invention provides novel heterocyclic compounds as anticancer agents, especially as estrogen receptor (ER) antagonists/ degraders and process for their preparation.  
WO/2017/044575A1
A genus of arylsulfonamide derivatives of heterocyclic constrained tricyclic compounds is disclosed. The compounds are of the following genus: The compounds induce FOXO1 transcription factor translocation to the nucleus by modulating PP2...  
WO/2017/032442A1
The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for ophthalmic devices as well as to ophthalmic devices comprising such compounds.  
WO/2016/200934A1
Compounds, compositions and methods useful for treating cancer and neiirodegeneration are provided. The compounds comprise a mitochondria-targeting moiety linked to β-lapachone or a β-lapachone derivative.  
WO/2016/192610A1
The present invention provides a compound having a novel acyloxime ester structure of the structure shown in a general formula I. The compound has a desirable ultraviolet absorption effect. The compound has characteristics of desirable s...  
WO/2016/192611A1
The present invention provides a compound having an acyloxime ester structure of the structural shown in a general formula I. The compound has a desirable ultraviolet absorption effect. The compound has characteristics of desirable solub...  
WO/2016/190475A1
The present invention relates to a photocleavable mass tag material and a use thereof and, to: a thiochromene type compound useful in matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry or in matrix-l...  
WO/2016/162389A1
The present invention relates to novel compounds which are useful as functionalized photoinitiators which may be used directly or after further functionalization in various photo-curable coating compositions, including varnishes, lacquer...  
WO/2016/161279A1
There are disclosed compounds of formula (I) that modulate or inhibit the enzymatic activity of indoleamine-2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, suc...  
WO/2016/161269A1
There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, vi...  
WO/2016/149975A1
The present invention provides a thioxanthone-aromatic amine compound and an organic light-emitting device applying same. The thioxanthone-aromatic amine compound comprises a compound as shown in a formula (I) or a formula (II), wherein ...  
WO/2016/126423A2
Z is CR4R5, C=CR4R5 SiR4R5, GeR4R5 NR4a, PR4a, P(O)R4a, O, S, SO, SO2, Se; SeO, SeO2, Te, TeO, or TeO2; R1 - R3 are the same or different at each occurrence and are D, aryl, heteroaryl, alkyl, amino, silyl, germyl, deuterated aryl, deute...  
WO/2016/126423A3
Z is CR4R5, C=CR4R5 SiR4R5, GeR4R5 NR4a, PR4a, P(O)R4a, O, S, SO, SO2, Se; SeO, SeO2, Te, TeO, or TeO2; R1 - R3 are the same or different at each occurrence and are D, aryl, heteroaryl, alkyl, amino, silyl, germyl, deuterated aryl, deute...  
WO/2016/097389A1
The invention relates to benzenesulfonamide derivatives of formula (I), the pharmaceutically acceptable addition salts thereof, the hydrates and/or solvates thereof, and the use of same as inverse agonists of retinoid-related orphan rece...  
WO/2016/087017A1
The invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices.  
WO/2016/081813A1
The present disclosure provides chalcogenopyrylium compounds, composite nanostructures comprising the chalcogenopyrylium compounds, and methods of using the compounds and/or composite nanostructures. For example, composite nanostructures...  
WO/2016/066134A1
The present invention relates to six-membered ring benzo derivatives as a DPP-4 inhibitor and a use thereof. In particular, the present invention relates to a compound as shown by formula I, a pharmaceutical composition containing the co...  
WO/2016/062587A1
The present invention relates to a compound of formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and G are as defined herein; and wherein the compound of formula (I) is optionally present as an agrochemically acceptable sa...  
WO/2016/003053A1
A compound for a phosphorescent host, according to the present invention, can have a wide band gap by adopting a donor-acceptor-donor (D-A-D) structure and have high triplet energy (ET) and a high glass transition temperature (Tg) by usi...  
WO/2015/183719A1
The invention describes the use of a water-based UV curable inkjet printing ink wherein the ink is basic due to the presence of a tertiary amine, allowing the complete dissolution of an acid functional photoinitiator of Formula I or Form...  
WO/2015/145371A1
The present invention relates to a compound of formula I, or an isotopic form, stereoisomer, a tautomer, a pharmaceutically acceptable salt, a solvate, a polymorph, a prodrug, N-oxide or S-oxide thereof; and processes for their preparati...  
WO/2015/129832A1
 The present invention is a radiosensitive resin composition containing: a polymer having a structural unit that contains the group represented by formula (1); and a radiosensitive acid generator. In formula (1), R1 is a substituted or...  
WO/2015/125572A1
A method for producing a thiopyranose compound represented by formula (2), which comprises reacting a compound represented by formula (1) with a sulfur compound. X represents a leaving group; A represents an oxygen atom or a sulfur atom;...  
WO/2015/107542A3
The present invention relates to a method of treating acne or psoriasis by topically administering Tazarotene substantially free of dimer impurity of formula 4,4-dimethyl-6-[4-(4,4-dimethylthiochroman-6-yl)-buta-1,3-di ynyl]-thiochroman.  
WO/2015/083663A1
A purpose of the present invention is to provide a polymerizable monomer having low contamination with respect to liquid crystals, high sensitivity to light of long wavelengths, and an exceptional sensitizing effect, and a polymer compou...  
WO/2015/076395A1
The present invention addresses the problem of providing: an acid- and radical-generating agent which has high sensitivity to an active energy ray having a wavelength of about 300 to 450 nm, can exhibit both high acid-generating ability ...  

Matches 1 - 50 out of 2,834